Subscribe

Spotlight -

Ghaith Noaiseh, MD

Ghaith Noaiseh, MD | Credit: University of Kansas

Associate Professor, University of Kansas, Allergy, Clinical Immunology, and Rheumatology

Articles by Ghaith Noaiseh, MD

Dazodalibep Eases Sjögren’s Dryness via CD40L Blockade: Ghaith Noaiseh, MD

Dazodalibep Eases Sjögren’s Dryness via CD40L Blockade: Ghaith Noaiseh, MD

ByGhaith Noaiseh, MD

November 12th 2026

Ghaith Noaiseh, MD, explains how dazodalibep’s CD40 ligand blockade works and reviews dryness and safety data from OASIZ-301 at ACR 2026.

Dazodalibep Lowers Sjögren’s Disease Activity: Ghaith Noaiseh, MD

Dazodalibep Lowers Sjögren’s Disease Activity: Ghaith Noaiseh, MD

ByGhaith Noaiseh, MD

November 12th 2026

Ghaith Noaiseh, MD, discusses phase 3 OASIZ-301 results showing dazodalibep reduced systemic disease activity in Sjögren’s disease at ACR 2026.

Latest Updated Articles

Trending on Rheumatology Live

Upadacitinib vs IL-17 Inhibitors in PsA, With Jessica Walsh, MD

Risankizumab Real World PsA Data From PERIS, With Fabian Proft, MD

INDIGO: Obexelimab Sustains IgG4-RD Flare Control, With John Stone, MD, MPH

IgG4-RD Treatment Guidelines Favor Steroid Sparing, B-cell Therapies

Afimetoran Meets Primary End Point Across 3 Doses in Phase 2 SLE Trial